Cargando…
Molecular target: pan-AKT in gastric cancer
The phosphatidylinositol 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) signalling pathway is involved in multiple cellular processes, including cell survival, proliferation, differentiation, metabolism and cytoskeletal reorganisation. The downstream effectors of this PI...
Autores principales: | Kang, Byung Woog, Chau, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511610/ https://www.ncbi.nlm.nih.gov/pubmed/32948630 http://dx.doi.org/10.1136/esmoopen-2020-000728 |
Ejemplares similares
-
Current status and future potential of predictive biomarkers for immune checkpoint inhibitors in gastric cancer
por: Kang, Byung Woog, et al.
Publicado: (2020) -
Targeting the Stroma in the Management of Pancreatic Cancer
por: Edwards, Penelope, et al.
Publicado: (2021) -
Taxanes in the Treatment of Advanced Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2016) -
HER2 Inhibition in Gastric Cancer—Novel Therapeutic Approaches for an Established Target
por: Fong, Caroline, et al.
Publicado: (2022) -
Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
por: Kang, Byung Woog, et al.
Publicado: (2017)